Cargando…
Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19
Randomized controlled trials designed to test cancer therapies often fail to clarify effectiveness in real-world settings. Herein, we explore lessons for trial development in oncology that can be learnt from the large-cohort, pragmatic RECOVERY trial involving patients hospitalized with COVID-19.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604917/ https://www.ncbi.nlm.nih.gov/pubmed/33139895 http://dx.doi.org/10.1038/s41571-020-00448-y |